Novel glycolipid and medicine for autoimmune disease containing the same as active ingredient
申请人:Yamamura Takashi
公开号:US20060148723A1
公开(公告)日:2006-07-06
The invention is a glycolipid useful in treating autoimmune diseases and a medicine thereof as active ingredient for autoimmune diseases,
wherein R
1
is an aldopyranose group, R
2
is a hydrogen atom or a hydroxyl group, R
3
is —CH
2
—, —CH(OH)—CH
2
— or —CH═CH—, R
4
is a hydrogen atom or CH
3
, x is 0-35, y and z represent integers satisfying y+z=0-3.
本发明是一种可用于治疗自身免疫性疾病的糖脂及其作为自身免疫性疾病活性成分的药物、
其中 R
1
是醛吡喃糖基,R
2
是氢原子或羟基,R
3
是-CH
2
-、-CH(OH)-CH
2
- 或-CH═CH-,R
4
是氢原子或 CH
3
x 为 0-35,y 和 z 代表满足 y+z=0-3 的整数。
US8367623B2
申请人:——
公开号:US8367623B2
公开(公告)日:2013-02-05
NOVEL GLYCOLIPID AND REMEDIAL AGENT FOR AUTOIMMUNE DISEASE CONTAINING THE SAME AS ACTIVE INGREDIENT